Physician

Subbarao Chavali, M.D.

According to 2025 Medicare claims, Subbarao Chavali, M.D. (NPI: 1669490769) practices cardiology in the Bay City, MI market, with the plurality of this provider's patient population coming from Bay, MI. Chavali uses personal NPI as billing NPI and primary practice location at 48708-7609. Chavali is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), Mosaic ACO (ACO ID: A5033), and Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Chavali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,011 traditional Medicare patients, billed 4,353 HCPCS/CPT codes, and received $242,173 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 7,970 prescription claims across 952 beneficiaries totaling $1,565,790 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 118 claims. Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $485,649 to $242,173. In contrast, Part D prescription costs have risen steadily, from $316,653 to $1,565,790. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $7,104 and ending at $27,256.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,750	10,333	$485,649
2016	1,621	9,744	$444,449
2017	1,765	11,088	$551,200
2018	1,673	10,111	$492,340
2019	1,335	7,481	$354,253
2020	1,145	7,473	$383,959
2021	1,141	5,209	$293,165
2022	1,394	5,808	$352,112
2023	1,052	4,550	$289,082
2024	1,011	4,353	$242,173

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	883	5,636	$316,653
2016	919	6,682	$377,479
2017	1,226	10,440	$689,863
2018	1,296	13,576	$1,010,696
2019	1,148	12,880	$1,119,585
2020	1,061	12,435	$1,166,083
2021	1,012	10,926	$1,161,782
2022	1,193	11,798	$1,489,710
2023	1,091	9,328	$1,588,637
2024	952	7,970	$1,565,790

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	95	$3,091
2016	26	199	$4,586
2017	57	419	$8,433
2018	189	974	$23,592
2019	108	842	$27,933
2020	17	250	$53,220
2021	16	184	$14,589
2022	N/R	118	$17,725
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	317	318	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	463	859	$82
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	234	247	$76
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	155	603	$38
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	458	775	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	735	51,884	$945,223
Xarelto	Rivaroxaban	196	14,710	$257,091
Brilinta	Ticagrelor	98	5,235	$72,114
Repatha Sureclick	Evolocumab	51	3,390	$63,681
Entresto	Sacubitril/Valsartan	19	1,410	$29,913

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$15	Cook Medical LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Subbarao Chavali, M.D.?

Tedicare shows public-source Medicare data for Subbarao Chavali, M.D. (NPI 1669490769), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Subbarao Chavali, M.D. have ACO affiliation data?

Subbarao Chavali, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), Mosaic ACO (MSSP, ACO ID A5033), and Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Subbarao Chavali, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Subbarao Chavali, M.D. have Open Payments data?

Subbarao Chavali, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.